1. Home
  2. MNKD vs BBN Comparison

MNKD vs BBN Comparison

Compare MNKD & BBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$3.98

Market Cap

877.0M

Sector

Health Care

ML Signal

HOLD

Logo BlackRock Taxable Municipal Bond Trust of Beneficial Interest

BBN

BlackRock Taxable Municipal Bond Trust of Beneficial Interest

HOLD

Current Price

$16.09

Market Cap

993.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNKD
BBN
Founded
1991
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
877.0M
993.0M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
MNKD
BBN
Price
$3.98
$16.09
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$8.69
N/A
AVG Volume (30 Days)
3.3M
130.1K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
6.90%
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$348,966,000.00
N/A
Revenue This Year
$35.81
N/A
Revenue Next Year
$11.89
N/A
P/E Ratio
$142.75
N/A
Revenue Growth
22.23
N/A
52 Week Low
$2.23
$15.38
52 Week High
$6.51
$17.45

Technical Indicators

Market Signals
Indicator
MNKD
BBN
Relative Strength Index (RSI) 79.50 46.62
Support Level $3.39 $16.06
Resistance Level $6.21 $16.69
Average True Range (ATR) 0.18 0.15
MACD 0.11 -0.01
Stochastic Oscillator 83.24 21.05

Price Performance

Historical Comparison
MNKD
BBN

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

About BBN BlackRock Taxable Municipal Bond Trust of Beneficial Interest

BlackRock Taxable Municipal Bond Trust is a diversified, closed-end management investment company. Its investment objective is to seek high current income, with a secondary objective of capital appreciation. The Trust seeks to achieve its investment objectives by investing in a portfolio of taxable municipal securities, including Build America Bonds (BABs), issued by state and local governments to finance capital projects such as public schools, roads, transportation infrastructure, bridges, ports and public buildings.

Share on Social Networks: